Ovarian cancer
Results
Phase 2/3
This trial compared trametinib with standard treatment for women with low grade serous ovarian or peritoneal cancer. It was for women whose cancer had come back or continued to grow despite treatment.
The trial was open for people to join between 2014 and 2018. The team published the results in 2022.
Recruitment start: 27 February 2014
Recruitment end: 10 April 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charlie Gourley
Cancer Research UK
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer
Novartis
NRG Oncology (formerly Gynecologic Oncology Group) United States
University of Glasgow
This is Cancer Research UK trial number CRUKE/12/028
Last reviewed: 13 June 2022
CRUK internal database number: 10084
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
